Names & News

New IASLC Foundation Board Member Posted: February 2018 Mr. Ratner is the Executive Chairman of Forest City Ratner Cos., a New York-based real estate development company, which he started in 1985. As the founder of one of the largest urban real estate developers in the country, Mr. Ratner has developed 52 ground-up projects in the…

Posted: February 2018 Tony S. K. Mok, BMSc, MD, has been elected to an International Oncologist seat of the 2019-2020 ASCO Board of Directors. Dr. Mok is the Li Shu Fan Medical Foundation Named Professor of Clinical Oncology and chair of clinical oncology at The Chinese University of Hong Kong. He co-founded the Lung Cancer…

Posted: February 2018 John V. Heymach, MD, PhD, has been named a Fellow (Medical Sciences) of the American Association for the Advancement of Science (AAAS). Dr. Heymach is the Chair of Thoracic/Head and Neck Medical Oncology and a Professor in the Departments of Thoracic Head and Neck Medical Oncology and Cancer Biology at The University…

Posted: December 2017 Yasushi Yatabe, MD, PhD, is the recipient of the 2017 IASLC Mary J. Matthews Pathology/Translational Research Award. Dr. Yatabe has served as Chief of the Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan, since 2000. Dr. Yatabe is Co-Editor of the IASLC Atlas of ALK and ROS1 Testing…

Posted: December 2017 Ramón Rami-Porta, MD, PhD, is the recipient of the 2017 IASLC Merit Award. Dr. Rami-Porta was appointed this year as the Clinical Chief of the Department of Thoracic Surgery at Hospital Universitari Mútua Terrassa, in Terrassa (Barcelona), Spain. He is also a Collaborating Professor of Thoracic Surgery at Escola Universitária Gimbernat, Autonomous…

Posted: December 2017 Tony Mok, BMSc, MD, FRCP(C), FRCP (Glasgow), FASCO, is the recipient of the 2017 IASLC Paul A. Bunn, Jr. Scientific Award. Prof. Mok is currently the Li Shu Fan Medical Foundation-Endowed Professor, Department of Clinical Oncology, Chinese University of Hong Kong, Prince of Wales Hospital. He also holds an honorary professorship at…

Posted: December 2017 Carolyn M. Dresler, MD, MPA, is the recipient of the 2017 IASLC Joseph W. Cullen Prevention/Early Detection Award. Dr. Dresler is currently the Associate Director for Medical & Health Sciences, Center for Tobacco Products, US Food & Drug Administration (FDA), a position she has held since 2012. As an IASLC Board member…

Posted: October 2017 Deric Savior, MD, has been appointed Head of Medical Oncology, Fox Chase Cancer Center at Temple University Hospital (TUH). Prior to this appointment, Dr. Savior led the Fox Chase thoracic oncology section at TUH, Philadelphia, USA, where he has served on the Cancer Committee, Institutional Review Board, Diversity Committee, and in the…

Posted: October 2017 Jean-Charles Soria, MD, PhD, has been appointed Senior Vice President, Head of Oncology Innovative Medicines at MedImmune, AstraZeneca. He will oversee research, translational sciences and early drug development in oncology within MedImmune. Prior to this appointment, Dr. Soria served as a Professor of Medicine and Medical Oncology at South-Paris University. He was…

Posted: October 2017 Frances A. Shepherd, OC, OOnt, MD, FRCPC, is the recipient of two recent oncology awards: She received the Tenth Annual Addario Foundation Keynote Lecture Award, which recognizes luminaries in the lung cancer field working to improve and prolong the lives of those with the disease, and its eradication. In addition, Dr. Shepherd…